Sign Up to like & get
recommendations!
0
Published in 2017 at "Nature Communications"
DOI: 10.1038/ncomms14060
Abstract: Somatic mutations in spliceosome genes are detectable in ∼50% of patients with myelodysplastic syndromes (MDS). We hypothesize that cells harbouring spliceosome gene mutations have increased sensitivity to pharmacological perturbation of the spliceosome. We focus on…
read more here.
Keywords:
u2af1 expressing;
mutant u2af1;
expressing cells;
u2af1 s34f ... See more keywords